-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, Shisiyao Group issued an announcement that Shijiazhuang Siyao's linezolid glucose injection was approved for production in imitation category 4, and it was deemed to have been reviewed
Linezolid, developed by Pfizer, is a synthetic oxazolidinone antibiotic, mainly used to treat infections caused by Gram-positive bacteria that are resistant to other antibiotics
Sales of terminal linezolid glucose injection in public medical institutions in China in recent years (unit: 100 million yuan)
Source: Terminal competition landscape of China's public medical institutions
According to data from Minai.
Source: Meinenet MED2.
In terms of consistency evaluation, linezolid glucose injection has been evaluated by 5 companies.
Source: Listed company announcements, Mi Nei.